Submitted by Anonymous (not verified) on 30 July 2025 - 11:41
Human medicines European public assessment report (EPAR): Nemluvio, nemolizumab, Date of authorisation: 12/02/2025, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Nemluvio, nemolizumab, Date of authorisation: 12/02/2025, Revision: 2, Status: Authorised